Literature DB >> 31995403

Characterization of Disease Phenotype in Very Preterm Infants with Severe Bronchopulmonary Dysplasia.

Katherine Y Wu1, Erik A Jensen2, Ammie M White3, Yan Wang4, David M Biko3, Kathleen Nilan1, María V Fraga2, Laura Mercer-Rosa4, Huayan Zhang2,5, Haresh Kirpalani2.   

Abstract

Rationale: Bronchopulmonary dysplasia (BPD) is a heterogenous condition with poorly characterized disease subgroups.
Objectives: To define the frequency of three disease components: moderate-severe parenchymal disease, pulmonary hypertension (PH), or large airway disease, in a referral cohort of preterm infants with severe BPD. The association between each component and a primary composite outcome of death before hospital discharge, tracheostomy, or home pulmonary vasodilator therapy was assessed.
Methods: This was a retrospective, single-center cohort study of infants born at <32 weeks' gestation with severe BPD who underwent both chest computed tomography with angiography (CTA) and echocardiography between 40 and 50 weeks postmenstrual age between 2011 and 2015. Moderate-severe parenchymal lung disease was defined as an Ochiai score ≥8 on CTA. PH was diagnosed by echocardiogram using standard criteria. Large airway disease was defined as tracheomalacia or bronchomalacia on bronchoscopy and/or tracheoscopy or CTA.Measurements and Main
Results: Of 76 evaluated infants, 73 (96%) were classifiable into phenotypic subgroups: 57 with moderate-severe parenchymal disease, 48 with PH, and 44 with large airway disease. The presence of all three disease components was most common (n = 23). Individually, PH and large airway disease, but not moderate-severe parenchymal disease, were associated with increased risk for the primary study outcome. Having more disease components was associated with an incremental increase in the risk for the primary outcome (2 vs. 1: odds ratio, 4.9; 95% confidence interval, 1.4-17.2 and 3 vs. 1: odds ratio, 12.8; 95% confidence interval, 2.4-70.0).Conclusions: Infants with severe BPD are variable in their predominant pathophysiology. Disease phenotyping may enable better risk stratification and targeted therapeutic intervention.

Entities:  

Keywords:  alveolar; bronchopulmonary dysplasia; parenchymal; pulmonary hypertension; tracheobronchomalacia

Mesh:

Year:  2020        PMID: 31995403      PMCID: PMC7258644          DOI: 10.1164/rccm.201907-1342OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  46 in total

Review 1.  Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia.

Authors:  Kurt R Stenmark; Steven H Abman
Journal:  Annu Rev Physiol       Date:  2005       Impact factor: 19.318

2.  Infant Pulmonary Function Testing and Phenotypes in Severe Bronchopulmonary Dysplasia.

Authors:  Edward G Shepherd; Brian J Clouse; Kathryn A Hasenstab; Swetha Sitaram; Daniel T Malleske; Leif D Nelin; Sudarshan R Jadcherla
Journal:  Pediatrics       Date:  2018-04-05       Impact factor: 7.124

3.  Effect of ventilation on mechanical properties and pressure-flow relationships of immature airways.

Authors:  R B Penn; M R Wolfson; T H Shaffer
Journal:  Pediatr Res       Date:  1988-05       Impact factor: 3.756

Review 4.  Respiratory Phenotypes for Preterm Infants, Children, and Adults: Bronchopulmonary Dysplasia and More.

Authors:  Joseph M Collaco; Sharon A McGrath-Morrow
Journal:  Ann Am Thorac Soc       Date:  2018-05

5.  Evaluation of airway complications in high-risk preterm infants: application of flexible fiberoptic airway endoscopy.

Authors:  G J Downing; H W Kilbride
Journal:  Pediatrics       Date:  1995-04       Impact factor: 7.124

Review 6.  Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia.

Authors:  Christian P Speer
Journal:  Neonatology       Date:  2009-06-04       Impact factor: 4.035

7.  Safety and efficacy of flexible endoscopy in children with bronchopulmonary dysplasia.

Authors:  R C Cohn; C Kercsmar; D Dearborn
Journal:  Am J Dis Child       Date:  1988-11

Review 8.  Perspectives on neonatal and infant tracheostomy.

Authors:  Sara B DeMauro; Julie L Wei; Richard J Lin
Journal:  Semin Fetal Neonatal Med       Date:  2016-04-06       Impact factor: 3.926

9.  The economic impact of prematurity and bronchopulmonary dysplasia.

Authors:  María Álvarez-Fuente; Luis Arruza; Marta Muro; Carlos Zozaya; Alejandro Avila; Paloma López-Ortego; Carmen González-Armengod; Alba Torrent; Jose Luis Gavilán; María Jesús Del Cerro
Journal:  Eur J Pediatr       Date:  2017-09-09       Impact factor: 3.183

10.  Neonatal Pulmonary Magnetic Resonance Imaging of Bronchopulmonary Dysplasia Predicts Short-Term Clinical Outcomes.

Authors:  Nara S Higano; David R Spielberg; Robert J Fleck; Andrew H Schapiro; Laura L Walkup; Andrew D Hahn; Jean A Tkach; Paul S Kingma; Stephanie L Merhar; Sean B Fain; Jason C Woods
Journal:  Am J Respir Crit Care Med       Date:  2018-11-15       Impact factor: 30.528

View more
  17 in total

1.  Risk factors and bronchopulmonary dysplasia severity: data from the Spanish Bronchopulmonary Dysplasia Research Network.

Authors:  Cristina Ramos-Navarro; Elena Maderuelo-Rodríguez; Ana Concheiro-Guisán; Santiago Pérez-Tarazona; Santiago Rueda-Esteban; Ana Sánchez-Torres; Manuel Sánchez-Solís; Ester Sanz-López; Manuel Sánchez-Luna
Journal:  Eur J Pediatr       Date:  2021-10-01       Impact factor: 3.183

Review 2.  Bronchopulmonary Dysplasia: Then, Now, and Next.

Authors:  Michael C Tracy; David N Cornfield
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2020-09       Impact factor: 0.885

3.  A glucocorticoid-receptor agonist ameliorates bleomycin-induced alveolar simplification in newborn rats.

Authors:  Shoichi Ishikawa; Tohru Ogihara; Shigeo Yamaoka; Jun Shinohara; Shigeru Kawabata; Yoshinobu Hirose; Daisuke Nishioka; Akira Ashida
Journal:  Pediatr Res       Date:  2022-09-06       Impact factor: 3.953

4.  Central airway issues in bronchopulmonary dysplasia.

Authors:  Erik B Hysinger
Journal:  Pediatr Pulmonol       Date:  2021-04-24

5.  Bronchopulmonary dysplasia as a determinant of respiratory outcomes in adult life.

Authors:  Joseph M Collaco; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2021-03-17

6.  Update in Pediatrics 2020.

Authors:  Erick Forno; Steven H Abman; Jagdev Singh; Mary E Robbins; Hiran Selvadurai; Paul T Schumacker; Paul D Robinson
Journal:  Am J Respir Crit Care Med       Date:  2021-08-01       Impact factor: 30.528

Review 7.  Predicting Long-Term Respiratory Outcomes in Premature Infants: Is It Time to Move beyond Bronchopulmonary Dysplasia?

Authors:  Deepak Jain; Alexander Feldman; Subhasri Sangam
Journal:  Children (Basel)       Date:  2020-12-10

Review 8.  Pulmonary hypertension in the child with bronchopulmonary dysplasia.

Authors:  Kelsey W Malloy; Eric D Austin
Journal:  Pediatr Pulmonol       Date:  2021-08-05

9.  Disease Phenotyping of Infants with Severe Bronchopulmonary Dysplasia.

Authors:  Erica Mandell; Erik B Hysinger; Sharon A McGrath-Morrow
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

Review 10.  Phenotypes of Bronchopulmonary Dysplasia.

Authors:  Shih-Hsin Wang; Po-Nien Tsao
Journal:  Int J Mol Sci       Date:  2020-08-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.